ARTICLE | Clinical News
ACTOplus met XR pioglitazone/extended-release metformin regulatory update
May 18, 2009 7:00 AM UTC
FDA approved extended-release ACTOplus met XR to treat Type II diabetes in adults already receiving Actos pioglitazone and metformin or who have inadequate glycemic control on Actos or metformin alon...